Faculty Authored
Taking on the Role of Lawyer: Transactional Skills, Transnational Issues, and Commercial Law
Temple law professor Susan DeJarnatt and University of Verona professor Paolo Butturini have published an article in the Southern Illinois University Law Journal about Temple Law School’s Introduction to Transactional Skills (ITS) program. Their article focuses on how the ITS model could be adapted to expand the teaching of experiential learning in law school.
“And They’re Off”: The Arms Race for the COVID Legal Services Market has Begun
Temple 10-Q Editor, Jonathan Broder (LAW ’83), discusses the rise of a new legal market as law firms develop COVID-19 resource centers.
Resolving the Crowdfunding Conundrum: The Experience of the United States and Spain
Temple Law Professor Rafael Porrata-Doria, Jr. shares his recent paper analyzing issues surrounding business crowdfunding from a United States and Spanish perspective.
Don’t Just Do Something—Stand There! A Modest Proposal for a Model Standstill/Tolling Agreement
10-Q Editor, Jonathan Lipson and Norman Powell, Partner at Young Conaway, propose a standstill and tolling agreement to aid businesses during the COVID-19 crisis
AI’s role in corporate transactions? Still gotta long way to go.
Richard Pasquier, Partner at Practus LLP, discusses the issues with and future of using Artificial Intelligence for due diligence inquiries.
“Spit-balling” Enterprise Risk in the Time of COVID – 19: What You Better Be Doing if You’re Not Already
The Editors report on COVID – 19 business risk management issues and recommendations.
Artificial Intelligence, Finance, and the Law
Temple Law’s Professor Tom Lin discusses risks in financial artificial intelligence and recommendations for the future.
Improving Economic Policies for the American Territories
Temple Law’s own Professor Tom Lin offers three innovative proposals to improve economic conditions in the US territories.
Examining Purdue Pharma
Recently, I (along with colleagues at other law schools) asked that an “examiner” be appointed in the Purdue Pharma chapter 11 bankruptcy case, pending in the Southern District of New York. Although the Bankruptcy Court has not yet acted on that request (technically, it was in the form of a letter to the United States